SPRAGUE JOHN M (Chief Financial Officer) sold 15.8% of their position (4.17K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $3.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2020ACC: 0000899243-20-006668
Officer· Chief Financial Officer
Since Jul 2018
+15.83K
Net shares
Net buyer
$3.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 4.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
61.0%
2/21/2020
16.39K→26.39K
Common Stock
Direct
Shares
−4.17K
Price / share
$0.82
Trade value
$3.42K
% of position
15.8%
2/24/2020
26.39K→22.22K
Total
Net shares
+5.83K
Net value
-$3.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2020 | M · Option Exercise | +10K | — | — | 61.0% | 16.39K | 26.39K |
| Common Stock Direct | 2/24/2020 | S · Sale | −4.17K | $0.82 | $3.42K | 15.8% | 26.39K | 22.22K |
| Total | +5.83K | -$3.42K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
Held after
20K
Exercisable
—
2/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock10K shares | 2/21/2020 | M · Option Exercise | +10K | — | 20K |